Delivery Order SPE2DB24D9238-SPE2DB24FDQML

Award Date 8/19/24
Potential Completion Date 9/10/24
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,126.98, is for the delivery of 4,565,563,472 doses of the YF-VAX 1 DOSE VIALS vaccine. The order has a completion date of September 12, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This is a $1,690.47 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4,565,058,724 doses of the YF-VAX vaccine, with a completion date of June 24, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, running through December...
This is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,453.68 firm fixed-price contract is for the delivery of 4,567,616,790 doses of the YF-VAX 1 vaccine. The order has an ultimate completion date of April 2, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,634.90, is for the supply of 4,565,752,490 doses of the YF-VAX 1 vaccine. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which runs through December 31, 2025. The IDC allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,512,925 doses of the YF-VAX vaccine, with a ceiling value of $11,269.80 and a completion date of December 10, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $27,835.50 contract is for the supply of 4,567,268,544 doses of the YF-VAX 1 DOSE VIALS product, with a performance period ending on March 6, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,507.92 firm fixed-price delivery order is for 4,565,058,721 doses of the YF-VAX vaccine, with a completion date of July 3, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, valued at $4,507.92, is for the provision of 4566541595 doses of the YF-VAX vaccine. The order has an ultimate completion date of December 13, 2024 and is not associated with any set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the procurement of 4,566,429 doses of the YF-VAX vaccine, with a total ceiling value of $11,833.29. The contract has a period of performance through November 29, 2024. DMS Pharmaceutical Group holds a larger single-award Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The $2,535.55 contract is to provide 4,564,239,661 doses of the YF-VAX 1 vaccine. This delivery order is part of a larger indefinite delivery contract worth up to $4,999,999 between DMS Pharmaceutical Group and DLA to supply a broad range of pharmaceutical products and medical supplies to military health...
  • SPE2DB24D9238
    Indefinite Delivery Contract
  • SPE2DB24D9238-SPE2DB24FDQML
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,507.92 contract is for the delivery of 4,565,549,284 doses of the YF-VAX 1 vaccine, with a period of performance through September 10, 2024.

DMS Pharmaceutical Group Inc. holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows for the issuance of firm fixed-price delivery orders to fulfill recurring medical supply needs of military health facilities worldwide. This award is not set aside and leverages DMS Pharmaceutical Group's status as a woman-owned small business to secure direct contract awards supporting the DLA's Medical Supply Chain division. The contract supports the diverse pharmaceutical requirements of the Department of Defense healthcare system.

Generated 11/18/24, 9:44 AM